bioRxivCancer BiologyPreprint
High Throughput Transcriptomics to Understand Chemical Drivers of Aggressive Breast Cancer Subtypes
K. E. Sala-Hamrick, A. Tapaswi, K. M. Polemi, V. K. Nguyen, J. A. Colacino
Abstract
BackgroundThe impact of chemical exposures on breast cancer progression is poorly characterized and may influence the development of more severe and aggressive subtypes. ObjectivesThere is a suite of toxicants, including metals, pesticides, and personal care product compounds, which are commonly detected at high levels in US Center for Disease Controls National Health and Nutrition Examination Survey (NHANES) chemical biomarker screens. To characterize the impact of these toxicants on breast cancer pathways, we performed high throughput dose-response transcriptomic analysis of toxicant exposed breast cells. MethodsWe treated non-tumorigenic mammary epithelial cells, MCF10A, with 21 chemicals at four doses (25nM, 250nM, 2.5{micro}M, 25{micro}M) for 48 hours. We conducted RNA-sequencing for these 408 samples, adapting the PlexWell plate-based RNA-sequencing method to analyze changes in gene expression resulting from these exposures. For each chemical, we calculated gene and biological pathway specific benchmark doses using BMDExpress2, identifying differentially expressed genes and generating the best fit benchmark dose models for each gene. We employed enrichment testing to test whether each chemicals upregulated or downregulated genes were over-represented in a biological process or pathway. We contextualized benchmark doses relative to human population biomarker concentrations in NHANES. ResultsOverall, significant changes in gene expression varied across doses of each chemical and benchmark dose modeling revealed dose-responsive alterations of thousands of different genes. Comparison of benchmark data to NHANES chemical biomarker concentrations indicated an overlap between actual exposure levels and levels sufficient to cause a gene expression response. Enrichment and cell deconvolution analyses showed benchmark dose responses correlated with changes in cancer and breast cancer related pathways, including induction of basal-like characteristics for some chemicals, including p,p-DDE, lead, copper, and methyl paraben. DiscussionThese analyses revealed that these 21 chemicals induce significant changes in pathways involved in breast cancer initiation and progression at human exposure relevant doses.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploring the Influence of Chemical Exposures in Breast Cancer Disparities: High-Throughput Transcriptomic Analysis in Normal Breast Cells from Diverse Donors
Neil Zhao, Peiyao Zhao, … Justin A. Colacino·bioRxiv·Feb 24, 2026
- Identifying the Link Between Chemical Exposures and Breast Cancer in African American Women via ToxCast High Throughput Screening Data
K. Polemi, V. K. Nguyen, … J. Colacino·bioRxiv·Jan 22, 2021
- Applying Cell Painting in Non-Tumorigenic Breast Cells to Understand Impacts of Common Chemical Exposures
Anagha Tapaswi, Nicholas I. Cemalovic, … Justin A. Colacino·Toxicology in VitroPeer-reviewed·May 3, 2024
- Environmental chemical mixtures reprogram mammary epithelial development to epigenetic states associated with breast cancer
Meadow E. Parrish, Meloryn Seraj, … Charlotte Kuperwasser·bioRxiv·Apr 3, 2026
- Exposure to p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) Perturbs Cell State and Stem Cell Markers and Induces an Epidermal Phenotype in Human Breast Cells
Jenna L Miller, Anagha Tapaswi, … Justin A. Colacino·bioRxiv·Oct 20, 2026
- Differential Cytotoxicity of PVP-Copper Nanoparticles in Breast Cancer Cell Lines: Insights from Basal Transcriptomic Profiles
Anelise Goncalves Silva, Izaque Junior Oliveira Silva, … Cyro von Zuben de Valega Negrão·bioRxiv·Sep 22, 2026